Structures by: Karamertzanis P. G.
Total: 29
C7H5ClO2
C7H5ClO2
CrystEngComm (2008) 10, 12 1848
a=14.6382(16)Å b=3.8142(6)Å c=23.812(3)Å
α=90.00° β=101.146(11)° γ=90.00°
C8H8O2
C8H8O2
CrystEngComm (2008) 10, 12 1848
a=4.831(3)Å b=19.420(6)Å c=7.7608(19)Å
α=90.00° β=106.87(3)° γ=90.00°
C15H13ClO4
C15H13ClO4
CrystEngComm (2008) 10, 12 1848
a=3.8267(3)Å b=23.260(2)Å c=7.65020(10)Å
α=90.00° β=104.372(7)° γ=90.00°
C22H8I2O2
C22H8I2O2
Acta Crystallographica Section B (2005) 61, 5 511-527
a=4.2020(10)Å b=20.956(4)Å c=9.276(2)Å
α=90.00° β=100.63(3)° γ=90.00°
C3H4N2O2
C3H4N2O2
Acta Crystallographica Section B (2005) 61, 5 511-527
a=9.3538(7)Å b=12.1757(11)Å c=7.2286(6)Å
α=90° β=104.593(4)° γ=90°
C9H9N3O5
C9H9N3O5
Acta Crystallographica Section B (2005) 61, 5 511-527
a=12.5693(4)Å b=4.85310(10)Å c=17.2663(5)Å
α=90° β=99.1624(15)° γ=90°
Azetidine
C3H7N1
Acta Crystallographica Section B (2005) 61, 5 511-527
a=9.507(3)Å b=9.122(3)Å c=9.790(3)Å
α=90° β=117.469(4)° γ=90°
2,6-dibromo-1-chloro-4-fluorobenzene
C6H2Br2ClF
Acta Crystallographica Section B Structural Science (2009) 65, 2 107-125
a=3.8943(5)Å b=13.5109(17)Å c=14.4296(17)Å
α=90.00° β=93.636(2)° γ=90.00°
2-amino-4-methylpyrimidine, 2-methylbenzoic acid
(C6H7N3),(C7H8O2)
Acta Crystallographica Section B Structural Science (2009) 65, 2 107-125
a=7.2795(10)Å b=13.6699(18)Å c=12.6695(16)Å
α=90.00° β=96.646(3)° γ=90.00°
C3H4O1
C3H4O1
Acta Crystallographica Section B Structural Science (2009) 65, 2 107-125
a=6.970(3)Å b=9.514(5)Å c=9.752(5)Å
α=90° β=90° γ=90°
(est)(pfn)
C28H22F8O2
Crystal Growth & Design (2015) 15, 3 1492
a=13.827(2)Å b=7.142(4)Å c=23.804(3)Å
α=90° β=90.925(5)° γ=90°
(bes)(dmn)
C30H36O2
Crystal Growth & Design (2015) 15, 3 1492
a=7.4099(4)Å b=15.8244(9)Å c=19.9836(12)Å
α=90° β=90° γ=90°
(bes)bhq)
C31H33NO2
Crystal Growth & Design (2015) 15, 3 1492
a=7.395(8)Å b=18.402(19)Å c=18.563(19)Å
α=90° β=90° γ=90°
Naproxen
C14H14O3
Crystal Growth & Design (2011) 11, 12 5659
a=25.8301(13)Å b=15.4939(4)Å c=5.9465(2)Å
α=90° β=90° γ=90°
Beta resoryclic acid form I
C7H6O4
Crystal growth & design (2011) 11, 1 210-220
a=23.1978(4)Å b=5.5469(1)Å c=5.1980(1)Å
α=90° β=92.215(1)° γ=90°
Beta resoryclic acid hemihydrate
2(C7H6O4),H2O
Crystal growth & design (2011) 11, 1 210-220
a=7.0270(4)Å b=9.5449(4)Å c=11.1763(5)Å
α=96.684(4)° β=104.319(5)° γ=98.903(4)°
Beta resoryclic DMSO hemisolvate
2(C7H6O4),C2H6OS
Crystal growth & design (2011) 11, 1 210-220
a=6.39832(12)Å b=11.7099(3)Å c=23.2362(5)Å
α=90° β=90° γ=90°
Beta resoryclate pyridinium salt
C7H5O4,C5H6N
Crystal growth & design (2011) 11, 1 210-220
a=11.7363(4)Å b=8.5691(2)Å c=11.8310(4)Å
α=90° β=115.973(5)° γ=90°
5-Ethynyl-2,4(1H,3H)-pyrimidinedione - eniluracil
C6H4N2O2
Crystal Growth & Design (2008) 8, 9 3474
a=9.0169(3)Å b=6.8086(2)Å c=9.3777(3)Å
α=90.00° β=101.2085(17)° γ=90.00°
C13H10N4O5
C13H10N4O5
Crystal Growth & Design (2005) 5, 6 2197
a=4.6868(3)Å b=18.4268(12)Å c=14.7201(9)Å
α=90.00° β=90.5000(10)° γ=90.00°
C13H12N4O6
C13H12N4O6
Crystal Growth & Design (2005) 5, 6 2197
a=24.744(5)Å b=7.3803(15)Å c=3.7360(7)Å
α=90.00° β=96.390(4)° γ=90.00°
4-dimethylaminopyridinium maleate
C7H11N2,C4H3O4
Crystal Growth & Design (2009) 9, 6 2881
a=13.127(3)Å b=7.599(2)Å c=12.576(3)Å
α=90.00° β=114.237(4)° γ=90.00°
4-dimethylaminopyridinium terephthalate
C7H11N2,0.5(C8H4O4)
Crystal Growth & Design (2009) 9, 6 2881
a=6.9285(7)Å b=15.7989(16)Å c=9.6739(10)Å
α=90.00° β=110.646(2)° γ=90.00°
4-Dimethylaminopyridinium fumarate-fumaric
C7H11N2,0.5(C4H4O4),0.5(C4H2O4)
Crystal Growth & Design (2009) 9, 6 2881
a=7.4036(13)Å b=8.1567(14)Å c=10.1469(17)Å
α=81.381(3)° β=89.228(3)° γ=70.789(3)°
4-Dimethylaminopyridinium phthalate
C7H11N2,C8H5O4
Crystal Growth & Design (2009) 9, 6 2881
a=22.130(3)Å b=8.7473(11)Å c=15.3325(19)Å
α=90.00° β=111.525(2)° γ=90.00°
4-dimethylaminopyridinium isophthalate
C7H11N2,0.5(C8H4O4)
Crystal Growth & Design (2009) 9, 6 2881
a=18.070(3)Å b=31.806(5)Å c=6.8941(10)Å
α=90.00° β=90.00° γ=90.00°
Pyridine fumaric acid
2(C5H5N1),C4H4O4
Crystal Growth & Design (2009) 9, 6 2881
a=3.8195(6)Å b=10.2834(15)Å c=17.067(3)Å
α=90.00° β=91.436(3)° γ=90.00°
C10H10N2S3
C10H10N2S3
Acta Crystallographica Section B Structural Science (2009) 65, 2 107-125
a=13.060(3)Å b=9.738(2)Å c=9.335(2)Å
α=90.00° β=105.800(3)° γ=90.00°
(bes)(phe)
C32H34O2
Crystal Growth & Design (2015) 15, 3 1492
a=7.3490(7)Å b=18.3630(18)Å c=18.6054(18)Å
α=90° β=90° γ=90°